Evaluation of the criticality of in vitro neuronal networks: Toward an assessment of computational capacity
Abstract
Novel computing hardwares are necessary to keep up with today's increasing demand for data storage and processing power. In this research project, we turn to the brain for inspiration to develop novel computing substrates that are self-learning, scalable, energy-efficient, and fault-tolerant. The overarching aim of this work is to develop computational models that are able to reproduce target behaviors observed in in vitro neuronal networks. These models will be ultimately be used to aid in the realization of these behaviors in a more engineerable substrate: an array of nanomagnets. The target behaviors will be identified by analyzing electrophysiological recordings of the neuronal networks. Preliminary analysis has been performed to identify when a network is in a critical state based on the size distribution of network-wide avalanches of activity, and the results of this analysis are reported here. This classification of critical versus non-critical networks is valuable in identifying networks that can be expected to perform well on computational tasks, as criticality is widely considered to be the state in which a system is best suited for computation. This type of analysis is expected to enable the identification of networks that are well-suited for computation and the classification of networks as perturbed or healthy.
- Publication:
-
arXiv e-prints
- Pub Date:
- July 2019
- DOI:
- 10.48550/arXiv.1907.02351
- arXiv:
- arXiv:1907.02351
- Bibcode:
- 2019arXiv190702351H
- Keywords:
-
- Quantitative Biology - Neurons and Cognition;
- Computer Science - Emerging Technologies
- E-Print:
- For presentation at the workshop "Novel Substrates and Models for the Emergence of Developmental, Learning and Cognitive Capabilities," 9th Joint IEEE International Conference on Development and Learning and on Epigenetic Robotics (IEEE ICDL-EPIROB 2019), Oslo, Norway. (website: http://www.nichele.eu/ICDL-EPIROB_NSM/ICDL-EPIROB_SNM.html)